167 related articles for article (PubMed ID: 2998825)
1. Comparison of the effects of detomidine and xylazine on some alpha 2-adrenoceptor-mediated responses in the central and peripheral nervous systems.
Virtanen R; MacDonald E
Eur J Pharmacol; 1985 Sep; 115(2-3):277-84. PubMed ID: 2998825
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular action of detomidine, a sedative and analgesic imidazole derivative with alpha-agonistic properties.
Savola JM; Ruskoaho H; Puurunen J; Kärki NT
Eur J Pharmacol; 1985 Nov; 118(1-2):69-76. PubMed ID: 2867913
[TBL] [Abstract][Full Text] [Related]
3. Effects of alpha-adrenoceptor antagonists on the mydriatic and bradycardic effects of detomidine.
Hanson CE; Hsu WH
Arch Int Pharmacodyn Ther; 1987 Jun; 287(2):291-8. PubMed ID: 2888443
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the alpha 1- and alpha 2-adrenoceptor effects of detomidine, a novel veterinary sedative analgesic.
Virtanen R; Nyman L
Eur J Pharmacol; 1985 Jan; 108(2):163-9. PubMed ID: 2984021
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the sedative effects of three alpha 2-adrenoceptor agonists (romifidine, detomidine and xylazine) in the horse.
England GC; Clarke KW; Goossens L
J Vet Pharmacol Ther; 1992 Jun; 15(2):194-201. PubMed ID: 1359161
[TBL] [Abstract][Full Text] [Related]
6. Xylazine-induced mydriasis in rats and its antagonism by alpha-adrenergic blocking agents.
Hsu WH; Lee P; Betts DM
J Vet Pharmacol Ther; 1981 Jun; 4(2):97-101. PubMed ID: 6130161
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological evidence for the involvement of alpha-2 adrenoceptors in the sedative effect of detomidine, a novel sedative-analgesic.
Virtanen R; Ruskoaho H; Nyman L
J Vet Pharmacol Ther; 1985 Mar; 8(1):30-7. PubMed ID: 2859378
[TBL] [Abstract][Full Text] [Related]
8. Increased alpha 1- and decreased alpha 2-adrenoceptor sensitivities upon chronic treatment with imipramine in mediating cardiovascular responses in pithed rats.
Rhim BY; Jung HO; Yu DH; Hong KW
Arch Int Pharmacodyn Ther; 1987 Nov; 290(1):77-91. PubMed ID: 2895612
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular and sedative alpha-adrenoceptor effects of detomidine-like arylalkyl imidazoles and associated derivatives.
Savola JM; Ruskoaho H; Salonen JS; Puurunen J; Karjalainen A; Kurkela K; Kärki NT
Arzneimittelforschung; 1988 Jan; 38(1):29-35. PubMed ID: 2835056
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of food intake in rats by the alpha 2-adrenoceptor agonists xylazine and detomidine.
Majeed NH; Mohammad FK; Ayoub RS
Pharmacol Res; 1991 May; 23(4):415-9. PubMed ID: 1678886
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular effects of medetomidine, detomidine and xylazine in horses.
Yamashita K; Tsubakishita S; Futaok S; Ueda I; Hamaguchi H; Seno T; Katoh S; Izumisawa Y; Kotani T; Muir WW
J Vet Med Sci; 2000 Oct; 62(10):1025-32. PubMed ID: 11073071
[TBL] [Abstract][Full Text] [Related]
12. Evidence for medetomidine as a selective and potent agonist at alpha 2-adrenoreceptors.
Savola JM; Ruskoaho H; Puurunen J; Salonen JS; Kärki NT
J Auton Pharmacol; 1986 Dec; 6(4):275-84. PubMed ID: 2880852
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the selectivity, specificity and potency of medetomidine as an alpha 2-adrenoceptor agonist.
Virtanen R; Savola JM; Saano V; Nyman L
Eur J Pharmacol; 1988 May; 150(1-2):9-14. PubMed ID: 2900154
[TBL] [Abstract][Full Text] [Related]
14. Comparison of detomidine, butorphanol, flunixin meglumine and xylazine in clinical cases of equine colic.
Jochle W; Moore JN; Brown J; Baker GJ; Lowe JE; Fubini S; Reeves MJ; Watkins JP; White NA
Equine Vet J Suppl; 1989 Jun; (7):111-6. PubMed ID: 9118091
[TBL] [Abstract][Full Text] [Related]
15. An investigation of presynaptic alpha-adrenoceptor subtypes in the pithed rat heart and in the rat isolated vas deferens.
Docherty JR
Br J Pharmacol; 1984 May; 82(1):15-23. PubMed ID: 6145465
[TBL] [Abstract][Full Text] [Related]
16. Possible role of alpha-2 and alpha-1 adrenoceptors in the experimentally-induced depression of the central nervous system.
Harsing LG; Kapocsi J; Vizi ES
Pharmacol Biochem Behav; 1989 Apr; 32(4):927-32. PubMed ID: 2572006
[TBL] [Abstract][Full Text] [Related]
17. Time-dependent enhancement of xylazine-induced, alpha-2 adrenoceptor-mediated vasoconstriction in isolated and perfused canine pulmonary veins.
Haniuda M; Itoh N; Chiba S
J Pharmacol Exp Ther; 1989 Apr; 249(1):340-7. PubMed ID: 2565395
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of propofol for general anesthesia in premedicated horses.
Mama KR; Steffey EP; Pascoe PJ
Am J Vet Res; 1996 Apr; 57(4):512-6. PubMed ID: 8712516
[TBL] [Abstract][Full Text] [Related]
19. Effect of neuropeptide Y on alpha 2-adrenoceptor-mediated cardiovascular responses in the pithed rat.
Vila E; Macrae IM
Br J Pharmacol; 1990 Aug; 100(4):840-2. PubMed ID: 2169943
[TBL] [Abstract][Full Text] [Related]
20. Alpha 2-adrenoceptor blocking profile of SK&F 104078: further evidence for receptor subtypes.
Akers I; Coates J; Drew GM; Sullivan AT
Br J Pharmacol; 1991 Apr; 102(4):943-9. PubMed ID: 1677300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
